Effectiveness of T2* MRI in Cervical Spondylotic Myelopathy

Status Active, not recruiting

Clinical Trial Summary

Utilization of T2* MRI in predicting prognosis in patients with cervical spondylotic myelopathy (CSM)

Clinical Trial Description

Cervical spondylotic myelopathy (CSM), an age-related degenerative disease that is common worldwide, is mainly caused by compression of the spinal cord and may possibly lead to disability. Surgery to reduce direct compression of the spinal cord might alleviate disease progression; due to individual differences, some patients do not benefit from surgery. Prognostic prediction is important because it affects subsequent treatment decision making. Currently, prognosis is generally based on magnetic resonance imaging (MRI) with a detailed macrostructural evaluation of the spinal cord. Unfortunately, the use of conventional MRI indicators (e.g., increased intensity signal [ISI]) to predict CSM outcomes has been controversial because of their subjectivity or the insufficient information contained therein. A new biomarker, T2* MRI gray matter to white matter signal intensity ratio (GM/WM), is associated with demyelination and gliosis. Previous studies have shown that patients with CSM can have T2* MRI WM / GM changes at the early stage of disease, and the WM / GM value is increased, which is significantly higher than that of normal people, and is related to the spinal cord function score. However, the correlation between this index and long-term prognosis remains to be studied. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04955041
Study type	Observational
Source	Peking University Third Hospital
Contact
Status	Active, not recruiting
Phase
Start date	January 2010
Completion date	June 2022

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04952831` - Diffusion MRI in Cervical Spondylotic Myelopathy
Completed	`NCT00565734` - Surgical Treatment of Cervical Spondylotic Myelopathy	Phase 4
Completed	`NCT00506558` - The CSM Trial: A Multicenter Study Comparing Ventral to Dorsal Surgery for Cervical Spondylotic Myelopathy	Phase 3
Not yet recruiting	`NCT06377072` - Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy	Phase 3
Recruiting	`NCT00876603` - Anterior Vs Posterior Procedures for Cervical Spondylotic Myelopathy: Prospective Randomized Clinical Trial	N/A
Enrolling by invitation	`NCT03513679` - Gait in Adult Patients With Cervical Spondylotic Myelopathy	N/A
Completed	`NCT01257828` - Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)	Phase 3
Completed	`NCT04968054` - Comparison of IONM Between Remimazolam and Propofol	N/A
Active, not recruiting	`NCT03296592` - Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
Completed	`NCT01061697` - Pregabalin and Radicular Pain Study (PARPS)	Phase 4
Completed	`NCT03810781` - Postural Stability in Cervical Spinal Myelopathy
Recruiting	`NCT04936074` - Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy	N/A
Completed	`NCT00285337` - Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy	N/A
Completed	`NCT02539394` - Effect of Topical Corticosteroids on Dysphagia in Anterior Cervical Discectomy and Fusion	N/A
Recruiting	`NCT05149404` - The Application of Enhanced Recovery After Surgery Clinical Pathway in Posterior Cervical Spine Surgery